The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

Oncotarget

Volumn 1, Issue 8, 2010, Pages 751-756

  Nucera, Carmelo ^a   Lawler, Jack ^b   Hodin, Richard ^b   Parangi, Sareh ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; GLUTAMIC ACID; TUMOR MARKER; VALINE;

AMINO ACID SUBSTITUTION; BIOLOGICAL MODEL; CELL TRANSFORMATION; GENETICS; HUMAN; MISSENSE MUTATION; MORTALITY; PATHOLOGY; PHYSIOLOGY; REVIEW; THYROID TUMOR;

AMINO ACID SUBSTITUTION; CELL TRANSFORMATION, NEOPLASTIC; GLUTAMIC ACID; HUMANS; MODELS, BIOLOGICAL; MUTATION, MISSENSE; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VALINE;

EID: 79958055230     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.210     Document Type: Review

References (0)